Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.74−0.08 (-9.49%)
Close on Nov 17, 2026Market cap $68.60MP/E –Yield –
Anavex Life Sciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Anavex Life Sciences
Anavex Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?